ERS International Congress 2016 - Thematic Poster Prognostic variables in lung cancer I

Thematic Poster

Prognostic variables in lung cancer I

Chairs

Straubing (Germany)

Dublin (Ireland)

Athens (Greece)

Hong Kong SAR (Hong Kong)

Preoperative cell counts of white blood cell, neutrophil, lymphocyte and neutrophil/lymphocyte ratio as a predictive parameter of survival rate after complete resection for non-small cell lung cancer J. Hwang(Seoul, Republic of Korea)

Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy S. Ryuge(Sagamihara (Kanagawa prefecture), Japan)

Expression and clinical implications of the estrogen receptor β in lung adenocarcinoma N. Lalić(Sremska Kamenica, Republic of Serbia)

Locally advanced stage nonsmallcell cancers explode in hyperglisemia: A new prognostic factors? B. Kömürcüoğlu(Izmir, Turkey)

Prevalence of mutations in Romanian patients with non-squamous lung carcinoma evaluated through next generation sequencing T. Cernomaz(Iasi (Iasi), Romania)

Potential lung cancer biomarkers from bronchoalveolar lavage fluid using metabolomics approaches V. Ignacio Barrios(Ronda, Spain)

The effect of surgical specimen-derived phosphorus and lead concentrations in non-small cell lung cancer patients on disease course E. Yilmazel Uçar(Erzurum, Turkey)

Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) as a possible biomarker for lung cancer and/or COPD A. Loukeri(Nikaia (Piraeus), Greece)

Correlation of bim and noxa expression with clinicopathological features in NSCLC E. Chaini(Corfu, Greece)

Prevalence of molecular changes in resected pulmonary adenocarcinomas R. Chalela Rengifo(Barcelona, Spain)

Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer D. Marinova(Sofia, Bulgaria)

The role of HIF-1 pathway in non-small-cell lung cancer E. Kurtipek(Konya, Turkey)

Association of the endothelin-1 and endothelin A receptor genetic polymorphisms and non-small cell lung cancer in Taiwan C. Shih(Taichung, Taiwan)

Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer M. Bayraktaroglu(Istanbul, Turkey)

NKX2-1 impacts prognosis in early stage NSCLC not harboring TP53 mutations J. Moisés Lafuente(Barcelona, Spain)

Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma G. Ferrara(Edmonton (AB), Canada)

Serum hepcidin and iron are associated with non-small cell lung cancer stage K. Sato(Yamagata, Japan)

Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations T. Kato(Himeji, Japan)

CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation N. Xu(Shanghai, China)

Prognostic significance of the expressions of Axl and/or Gas6 in patients with completely resected lung adenocarcinoma C. Kim(Gyeonggi-do, Republic of Korea)